UK Markets closed
NIKKEI 225
22,573.66+378.28(+1.70%)HANG SENG
24,946.63+488.50(+2.00%)CRUDE OIL
41.95+0.94(+2.29%)
Axsome Therapeutics, Inc. (0HKF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
84.98+81.63 (+2,436.85%)
At close: 4:00PM BST
| Previous close | 3.35 |
| Open | 84.98 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 84.98 - 84.98 |
| 52-week range | 84.98 - 84.98 |
| Volume | 588 |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 3.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.58 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
These Stocks Would Have Doubled Your Money Last Year
Axsome Therapeutics and EverQuote had two of the biggest stock gains in 2019. Are they still buys today?
- Zacks
Axsome Focuses on Filling NDAs for Two CNS Candidates in 2020
Axsome's (AXSM) CNS pipeline candidates are advancing well. NDAs for AXS-05 to address MDD and AXS-07 as an acute treatment of migraine will be filed in Q4. Lack of a marketed product is a concern.
- Zacks
Axsome's NDA for Depressive Disorder Drug on Track in Q420
Axsome (AXSM) concludes a favorable pre-NDA meeting with the FDA officials for AXS-05 to treat major depressive disorder. The company is on course to file the NDA in Q4.
© 2020 Verizon Media. All rights reserved.
